Efficacy and Safety Study of Ingavirin® to Treat Influenza and Acute Respiratory Viral Infections in Patients 13-17 y.o.

Clinical trial NCT03206346 · COMPLETED

Trial details

NCT number: NCT03206346
Sponsor: Valenta Pharm JSC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Influenza, Human Acute Respiratory Infection Viral Infection Common Cold

Start date: 2012-01-01
Primary completion: 2012-11-01
Enrollment: 161

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.